- $91.77m
- -$51.58m
- CNY985.52m
- 91
- 99
- 35
- 88
Annual cashflow statement for Ihuman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.6 | -276 | -37.5 | -37.1 | 110 |
| Depreciation | |||||
| Non-Cash Items | 0.194 | 271 | 81.3 | 16.8 | 20.3 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 12.5 | 46.8 | 176 | 52 | 47.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.5 | 42.6 | 223 | 38.2 | 188 |
| Capital Expenditures | -0.529 | -2.39 | -15.9 | -32.3 | -6.59 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 0.332 | -26.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.529 | -2.39 | -15.9 | -32 | -32.8 |
| Financing Cash Flow Items | -10.9 | -3.1 | -57.6 | 0.097 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.3 | 58.5 | 572 | 0.41 | -6.96 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.28 | 98.8 | 757 | -6.32 | 195 |